Swiss National Bank’s Acadia Pharmaceuticals ACAD Stock Holding History

Swiss National Bank’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.22M	Buy	234,404 +1,500	+0.6%	+$35.8K	﹤0.01%	1347
2025 Q4	$6.22M	Buy	232,904 +5,800	+3%	+$139K	﹤0.01%	1231
2025 Q3	$4.85M	Buy	227,104 +20,100	+10%	+$475K	﹤0.01%	1349
2025 Q2	$4.47M	Sell	207,004 -2,500	-1%	-$46.5K	﹤0.01%	1355
2025 Q1	$3.48M	Sell	209,504 -2,600	-1%	-$47.2K	﹤0.01%	1458
2024 Q4	$3.89M	Buy	212,104 +2,900	+1%	+$46.8K	﹤0.01%	1480
2024 Q3	$3.22M	Sell	209,204 -1,400	-0.7%	-$23.4K	﹤0.01%	1580
2024 Q2	$3.42M	Hold	210,604	–	–	﹤0.01%	1513
2024 Q1	$3.89M	Buy	210,604 +800	+0.4%	+$19.8K	﹤0.01%	1452
2023 Q4	$6.57M	Sell	209,804 -22,600	-10%	-$540K	﹤0.01%	1112
2023 Q3	$4.84M	Sell	232,404 -14,900	-6%	-$405K	﹤0.01%	1299
2023 Q2	$5.92M	Sell	247,304 -14,800	-6%	-$329K	﹤0.01%	1210
2023 Q1	$4.93M	Sell	262,104 -31,000	-11%	-$590K	﹤0.01%	1283
2022 Q4	$4.67M	Buy	293,104 +6,000	+2%	+$93.8K	﹤0.01%	1354
2022 Q3	$4.7M	Buy	287,104 +2,000	+0.7%	+$32.4K	﹤0.01%	1322
2022 Q2	$4.02M	Hold	285,104	–	–	﹤0.01%	1453
2022 Q1	$6.91M	Buy	285,104 +20,500	+8%	+$496K	﹤0.01%	1236
2021 Q4	$6.18M	Hold	264,604	–	–	﹤0.01%	1319
2021 Q3	$4.39M	Hold	264,604	–	–	﹤0.01%	1555
2021 Q2	$6.45M	Sell	264,604 -7,800	-3%	-$176K	﹤0.01%	1306
2021 Q1	$7.03M	Buy	272,404 +3,000	+1%	+$132K	﹤0.01%	1241
2020 Q4	$14.4M	Buy	269,404 +4,500	+2%	+$223K	0.01%	759
2020 Q3	$10.9M	Buy	264,904 +4,800	+2%	+$207K	0.01%	773
2020 Q2	$12.6M	Buy	260,104 +36,100	+16%	+$1.73M	0.01%	688
2020 Q1	$9.46M	Buy	224,004 +16,500	+8%	+$680K	0.01%	681
2019 Q4	$8.88M	Buy	207,504 +4,100	+2%	+$178K	0.01%	827
2019 Q3	$7.32M	Buy	203,404 +2,700	+1%	+$81.9K	0.01%	893
2019 Q2	$5.37M	Sell	200,704 -5,100	-2%	-$130K	0.01%	1076
2019 Q1	$5.53M	Buy	205,804 +2,400	+1%	+$56K	0.01%	1017
2018 Q4	$3.29M	Buy	203,404 +30,000	+17%	+$583K	﹤0.01%	1241
2018 Q3	$3.6M	Hold	173,404	–	–	﹤0.01%	1338
2018 Q2	$2.65M	Hold	173,404	–	–	﹤0.01%	1510
2018 Q1	$3.9M	Buy	173,404 +6,600	+4%	+$183K	﹤0.01%	1202
2017 Q4	$5.02M	Buy	166,804 +3,900	+2%	+$125K	0.01%	1058
2017 Q3	$6.14M	Hold	162,904	–	–	0.01%	903
2017 Q2	$4.54M	Buy	162,904 +3,200	+2%	+$95.4K	0.01%	1054
2017 Q1	$5.49M	Buy	159,704 +1,900	+1%	+$67.1K	0.01%	932
2016 Q4	$4.55M	Buy	157,804 +4,400	+3%	+$116K	0.01%	1010
2016 Q3	$4.88M	Buy	153,404 +2,400	+2%	+$81.4K	0.01%	924
2016 Q2	$4.9M	Sell	151,004 -5,300	-3%	-$177K	0.01%	911
2016 Q1	$4.22M	Buy	156,304 +51,004	+48%	+$1.11M	0.01%	974
2015 Q4	$3.75M	Hold	105,300	–	–	0.01%	934
2015 Q3	$3.48M	Buy	105,300 +13,500	+15%	+$562K	0.01%	971
2015 Q2	$3.85M	Buy	91,800 +2,000	+2%	+$77.4K	0.01%	908
2015 Q1	$2.93M	Buy	89,800 +1,100	+1%	+$37.8K	0.01%	1063
2014 Q4	$2.82M	Buy	88,700 +2,300	+3%	+$65.2K	0.01%	1051
2014 Q3	$2.14M	Sell	86,400 -1,000	-1%	-$23.4K	0.01%	1147
2014 Q2	$1.97M	Hold	87,400	–	–	0.01%	1266
2014 Q1	$2.13M	Buy	87,400 +31,900	+57%	+$807K	0.01%	1176
2013 Q4	$1.39M	Hold	55,500	–	–	0.01%	1286
2013 Q3	$1.52M	Sell	55,500 -2,500	-4%	-$52.3K	0.01%	1179
2013 Q2	$1.05M	Buy	+58,000	New	+$799K	﹤0.01%	1386